Key result
High-sensitivity cardiac troponin I testing rapidly ruled out acute coronary syndrome in more patients than contemporary-sensitive testing (68.7% vs 52.4%) and reduced emergency department stay.
Why the study?
Does high-sensitivity cardiac troponin I (HS-cTnI) testing improve early rule-out of ACS and reduce emergency department length of stay compared to conventional CS-cTnI in patients with suspected ACS?
Observational (n=288)
Does high-sensitivity cardiac troponin I (HS-cTnI) testing improve early rule-out of ACS and reduce emergency department length of stay compared to conventional CS-cTnI in patients with suspected ACS?
High-sensitivity cardiac troponin I testing allows for more rapid rule-out of ACS and shorter emergency department stays compared to conventional troponin testing.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Lippi et al. (2017) conducted an observational in Suspected acute coronary syndrome (ACS) (n=288). High-sensitivity cardiac troponin I (HS-cTnI) immunoassay vs. Contemporary-sensitive (CS) cTnI immunoassay was evaluated on Rapid rule-out of acute coronary syndrome. High-sensitivity cardiac troponin I testing rapidly ruled out acute coronary syndrome in more patients than contemporary-sensitive testing (68.7% vs 52.4%) and reduced emergency department stay.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: